Spatial pattern of phenylketonuria disease determination using geographic information system in Lorestan province from 2006 to 2016

Document Type: Original Article

Authors

1 1. Department of Public Health, School of Health, Sabzevar University of Medical Sciences, Sabzevar, Iran

2 Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Science, Tehran, Iran

3 Departments of Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Department of Diseases, Health Network, Borujerd, Borujerd, Iran

5 Department of Health and Community Medicine, Faculty of Medicine, Dezful University of Medical Sciences, Dezful, Iran

6 Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran

Abstract

Introduction: Phenylketonuria(PKU) is a metabolic disorder that, if not detected and treated promptly, causes mental retardation. The use of the geographic information system (GIS) in favor of spreading the disease helps to control the disease. Therefore, the aim of this study was to determine the local pattern of the PKU disease using the GIS in Lorestan province from 2006 to 2016.
Methods: The current descriptive cross-sectional study was conducted on the patients diagnosed with PKU in Lorestan province from 2006 to 2016. The statistical population included all cases identified between April 2006 and March 2016. The ArcGIS 9.3 software was used to provide geographic maps of the incidence and frequency of the disease.
Results: The results showed that Nourabad county had the highest number of larvae with 22 (72.29%), and the most cases with PKU disease were with 2 cases (99.2%). According to GIS maps, the incidence of PKU from 2006 to 2016 was on an ascending tide. The highest incidence in these years was related to Nurabad with an average of 5.7 per 10,000 live births and the lowest incidence related to Boroujerd county with more than 0.53 per 10,000 live births.
Conclusion: According to the GIS map, Nourabad county has the highest incidence of PKU. Therefore, it is necessary to consider the majority of prevention programs for paternity screening and counseling couples, especially family marriages in the city, in order to reduce the incidence of this disease.

Keywords


 

1. Bernstein L, Burns C, Sailer-Hammons M, Kurtz A, Rohr F. Multiclinic Observations on the Simplified Diet in PKU. J Clin Nutr Metab. 2017; 2017:1-5. doi:10.1155/2017/4083293

2. Senemar S, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M. Epidemiological and clinical study of Phenylketonuria (PKU) disease in the National Screening Program of Neonates, Fars province, Southern Iran. Iran J Public Health. 2009;38(2):58-64.

3. Eijgelshoven I, Demirdas S, Smith TA, Van Loon JM, Latour S, Bosch AM. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands. Mol Genet Metab Rep. 2013; 109(3):237-42. doi:10.1016/j.ymgme.2013.05.003

4. Goodarzi E, Ghaderi E, Khazaei S, Alikhani A, Ghavi S, Mansori K, et al. The prevalence of transient and permanent congenital hypothyroidism in infants of Kurdistan Province, Iran (2006-2014). Int J Pediatr. 2017; 5(2):4309-18. doi:10.22038/ijp.2016.7902

5. Etemad K, Khazaei Z, Pordanjani SR, Shahsavand M, Ajam F, Riahi S-M, et al. Evaluation of the therapeutic interventions effects on body growth pattern of infants with congenital hypothyroidism. Biomed Res Ther. 2018; 5(4):2194-207. doi:10.15419/bmrat.v5i4.433

6. Kono K, Okano Y, Nakayama K, Hase Y, Minamikawa S, Ozawa N, et al. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology. 2005; 236(2):630-6. doi:10.1148/radiol.2362040611

7. Moradi K, Alibakhshi R. High risk of birth defects with PKU in Mast-e Ali village, Kermanshah province. J Kermanshah Univ Med Sci. 2014; 18(1):62-5.

8. Dos Santos LL, De Castro Magalhães M, De Oliveira Reis A, Starling ALP, Januário JN, da Fonseca CG, et al. Frequencies of phenylalanine hydroxylase mutations I65T, R252W, R261Q, R261X, IVS10nt11, V388M, R408W, Y414C, and IVS12nt1 in Minas Gerais, Brazil. Genet Mol Res. 2006; 5(1):16-23. PMID:16755493

9. Motamedi N, Goodarzi E, Pordanjani SR, Valizadeh R, Moradi Y, Sohrabivafa M, et al. Incidence of phenylketonuria in Lorestan province, West of Iran (2006-2016). Int J Pediatr. 2017; 5(40):4713-21. doi:10.22038/ijp.2017.21094.1770

10. Sipe NG, Dale P. Challenges in using geographic information systems (GIS) to understand and control malaria in Indonesia. Malar J. 2003; 2(1):36-44. doi:10.1186/1475-2875-2-36

11. Seif A, Rashidi M, Rozbahani R, Daheshti N, Poursafa P. GIS application in medical researches a solution for prevention from disease. J Esfahan Univ Med Sci. 2011;29(164):1-10.

12. Tanser FC, Le Sueur D. The application of geographical information systems to important public health problems in Africa. Int J Health Geogr. 2002; 1(1):4-13. doi:10.1186/1476-072X-1-4

13. Hassan A, Kenawy M, Kamal H, Abdel Sattar A, Sowilem M. GIS-based prediction of malaria risk in Egypt. East Mediterr Health J. 2003; 9 (‎4)‎, 548-558.

14. Boulos MK, Roudsari AV, Carson ER. Health geomatics: an enabling suite of technologies in health and healthcare. J Biomed Inform. 2001; 34(3):195-219. doi:10.1006/jbin.2001.1015

15. Magruder C, Burke M, Hann NE, Ludovic JA. Using information technology to improve the public health system. J Public Health Manag Pract. 2005; 11(2):123-30.

16. Habib A, Fallahzadeh MH, Kazeroni HR, Ganjkarimi AH. Incidence of phenylketonuria in Southern Iran. Iran J Med Sci. 2010; 35(2):137.

17. Badiee S, Morovatdar N, Hossini SMR, Norouzi F, Mina T. Epidemiological and clinical study of phenylketonouria (PKU) disease in Khorasan Province; Northeast Iran. Med J Mashhad Univ Med Sci. 2014; 57(3):571-8.

18. Madden M. Phenylketonuria: Defects in amino acid metabolism. Mol Med (SCJMM). 2004;5:57-61.

19. Kabiri M. A Report on the Incidence of phenylketonuria. Acta Medica Iranica. 1982;24(3-4):107-13.

20. Depatement G. Center of Noncommunicable Disease. Prevention and Control of Phenylketonuria Guideline. 2011:4-5.

21. Moradi P, Sari-Sarraf B, Khamnian Z, Dolatkhah R, Hadi S, Ghafari D, et al. Distribution Occurrence of Phenylketonuria in the World: A Systematic Review and Meta-Analysis. Depiction Health. 2016;6(4):1-12.

22. Koochmeshgi J, Bagheri A, Hosseini-Mazinani S. Incidence of phenylketonuria in Iran estimated from consanguineous marriages. J Inherit Metab Dis. 2002; 25(1):80-1.  doi:10.1023/A:1015154321142

23. Pangkanon S CW, Janejai N, Boonwanich W, Chaisomchit S. Detection of phenylketonuria by the newborn screening program in Thailand. Southeast Asian J Trop Med Public Health. 2009; 40(3):525-9. PMID:19842439

24. Senemar SA, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M. Epidemiological and clinical study of Phenylketonuria (PKU) disease in the National Screening Program of Neonates, Fars province, Southern Iran. Iran J Public Health. 2009; 38(2):58-64.